Marsh & McLennan Companies (NYSE:MRSH) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says

Key Points

• Keefe, Bruyette & Woods raised its price objective on Marsh & McLennan to $203 (from $200) with a "market perform" rating, implying roughly an 11.1% upside from the current share price.
• Q1 earnings beat: the company reported EPS of $3.29 vs. $3.21 expected and revenue of $7.30 billion (up ~7.6% YoY), with management highlighting organic growth initiatives and AI investments to support margins and client retention.
• Analyst sentiment is mixed—MarketBeat shows a consensus rating of Hold and an average price target of $205.33—while some brokers cut targets and a new regulatory-risk disclosure has increased investor uncertainty.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) had its price objective increased by equities research analysts at Keefe, Bruyette & Woods from $200.00 to $203.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a "market perform" rating on the financial services provider's stock. Keefe, Bruyette & Woods' target price would suggest a potential upside of 11.10% from the company's current price.

MRSH has been the topic of a number of other research reports. Weiss Ratings began coverage on shares of Marsh & McLennan Companies in a research note on Thursday, January 29th. They issued a "hold (c)" rating on the stock. Cantor Fitzgerald upped their target price on shares of Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an "overweight" rating in a research note on Monday, February 2nd. Evercore lowered their target price on shares of Marsh & McLennan Companies from $237.00 to $236.00 and set an "outperform" rating on the stock in a research note on Wednesday, January 7th. Raymond James Financial upgraded shares of Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 target price on the stock in a research note on Tuesday, February 17th. Finally, Barclays lowered their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $205.33.

Marsh & McLennan Companies Price Performance

NYSE:MRSH opened at $182.72 on Friday. The stock has a 50-day simple moving average of $173.49. The stock has a market cap of $88.46 billion, a P/E ratio of 21.68, a PEG ratio of 2.41 and a beta of 0.75. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 1.20. Marsh & McLennan Companies has a 1-year low of $164.89 and a 1-year high of $235.78.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.21 by $0.08. The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 15.42% and a return on equity of 31.60%. The company's revenue for the quarter was up 7.6% on a year-over-year basis. Equities analysts anticipate that Marsh & McLennan Companies will post 9.61 EPS for the current fiscal year.

Insider Activity at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,655 shares of the company's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the sale, the chief executive officer owned 116,811 shares of the company's stock, valued at $21,411,456.30. This represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.38% of the stock is owned by insiders.

Institutional Investors Weigh In On Marsh & McLennan Companies

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Numerai GP LLC increased its holdings in Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock worth $7,501,000 after acquiring an additional 33,729 shares in the last quarter. Rockland Trust Co. grew its holdings in Marsh & McLennan Companies by 801.6% during the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider's stock valued at $2,433,000 after buying an additional 10,734 shares in the last quarter. Barclays PLC grew its holdings in Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock valued at $443,844,000 after buying an additional 647,987 shares in the last quarter. Navera Investment Management Ltd. grew its holdings in Marsh & McLennan Companies by 7.0% during the 3rd quarter. Navera Investment Management Ltd. now owns 1,623,960 shares of the financial services provider's stock valued at $327,303,000 after buying an additional 105,954 shares in the last quarter. Finally, Bridges Investment Management Inc. grew its holdings in Marsh & McLennan Companies by 4.4% during the 3rd quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider's stock valued at $15,356,000 after buying an additional 3,177 shares in the last quarter. 87.99% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Q1 results beat expectations: non‑GAAP EPS $3.29 (beat) and revenue growth ~7.6%–8%, driven by Mercer and consulting strength — a core reason the shares rallied after the release. Read More.
• Positive Sentiment: Earnings call highlighted organic growth initiatives and AI investments that management says should drive margins and client retention long term — supportive for forward growth expectations. Read More.
• Neutral Sentiment: Analyst/market commentary notes valuation may be attractive after the pullback; some investors view the Q1 beat as confirming resilience, but upside is seen as tied to execution and managing expense pressures. Read More.
• Negative Sentiment: New regulatory risk disclosure: the company warned of a broad regulation-category risk that could materially affect financial performance — this fresh caveat increases investor uncertainty and likely weighed on the stock today. Read More.
• Negative Sentiment: Analyst pressure persists: Bank of America maintained a sell rating and some brokers recently trimmed price targets, which amplifies downside risk despite the beat and can trigger short‑term selling. Read More.
• Negative Sentiment: Reports note the shares slid after an analyst target cut prior to the regulatory disclosure — momentum from the Q1 beat has been partly offset by analyst actions. Read More.

About Marsh & McLennan Companies

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.